Old Web
English
Sign In
Acemap
>
Paper
>
PACIFIC: Overall Survival with Durvalumab versus Placebo after Chemoradiotherapy in Stage III NSCLC
PACIFIC: Overall Survival with Durvalumab versus Placebo after Chemoradiotherapy in Stage III NSCLC
2018
David Raben
Corinne Faivre-Finn
David R. Spigel
D. Daniel
A. Villegas
D. Vincente
Rina Hui
J. de Castro Carpeño
S Murakami
Luis Paz-Ares
Mustafa Ozguroglu
Takayasu Kurata
Alberto Chiappori
K.H. Lee
M de Wit
L. Poole
C. Wadsworth
Phillip A. Dennis
Scott Antonia
Keywords:
Stage III NSCLC
Placebo
Radiology
Chemoradiotherapy
Durvalumab
Oncology
Internal medicine
Medicine
overall survival
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]